(VIANEWS) – Fomento Economico Mexicano S.A.B. de C.V. (FMX), J & J Snack Foods Corp. (JJSF), World Wrestling Entertainment (WWE) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Fomento Economico Mexicano S.A.B. de C.V. (FMX)
16.9% sales growth and 12.66% return on equity
Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of chillers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. As of December 31, 2021, it operated 20,431 OXXO stores; 3,652 drugstores; and 567 OXXO GAS service stations. Fomento Económico Mexicano, S.A.B. de C.V. was founded in 1890 and is based in Monterrey, Mexico.
Earnings Per Share
As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $-0.27.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.66%.
Sales Growth
Fomento Economico Mexicano S.A.B. de C.V.’s sales growth for the next quarter is 16.9%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 180% and 38.5%, respectively.
Yearly Top and Bottom Value
Fomento Economico Mexicano S.A.B. de C.V.’s stock is valued at $94.85 at 10:22 EST, above its 52-week high of $87.88.
Volume
Today’s last reported volume for Fomento Economico Mexicano S.A.B. de C.V. is 135490 which is 78.08% below its average volume of 618244.
2. J & J Snack Foods Corp. (JJSF)
15.4% sales growth and 5.02% return on equity
J & J Snack Foods Corp. manufactures, markets, and distributes various nutritional snack foods and beverages to the food service and retail supermarket industries in the United States, Mexico, and Canada. It operates in three segments: Food Service, Retail Supermarkets, and Frozen Beverages. The company offers soft pretzels under the SUPERPRETZEL, PRETZEL FILLERS, PRETZELFILS, GOURMET TWISTS, MR. TWISTER, SOFT PRETZEL BITES, SOFTSTIX, SOFT PRETZEL BUNS, TEXAS TWIST, BAVARIAN BAKERY, SUPERPRETZEL BAVARIAN, NEW YORK PRETZEL, KIM & SCOTT'S GOURMET PRETZELS, SERIOUSLY TWISTED!, BRAUHAUS, AUNTIE ANNE'S, and LABRIOLA, as well as under the private labels. It also provides frozen juice treats and desserts under the LUIGI'S, WHOLE FRUIT, PHILLY SWIRL, SOUR PATCH, ICEE, and MINUTE MAID brands; churros under the TIO PEPE'S and CALIFORNIA CHURROS brands; and dough enrobed handheld products under the SUPREME STUFFERS and SWEET STUFFERS brands. In addition, the company offers bakery products, including biscuits, fig and fruit bars, cookies, breads, rolls, crumb, muffins, and donuts under the MRS. GOODCOOKIE, READI-BAKE, COUNTRY HOME, MARY B'S, DADDY RAY'S, and HILL & VALLEY brands, as well as under private labels; and frozen beverages under the ICEE, SLUSH PUPPIE, and PARROT ICE brands. J & J Snack Foods Corp. sells its products through a network of food brokers, independent sales distributors, and direct sales force. The company was founded in 1971 and is headquartered in Pennsauken, New Jersey.
Earnings Per Share
As for profitability, J & J Snack Foods Corp. has a trailing twelve months EPS of $2.22.
PE Ratio
J & J Snack Foods Corp. has a trailing twelve months price to earnings ratio of 64.11. Meaning, the purchaser of the share is investing $64.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.02%.
Moving Average
J & J Snack Foods Corp.’s value is under its 50-day moving average of $152.65 and under its 200-day moving average of $142.43.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 188.2% and 66.7%, respectively.
Volume
Today’s last reported volume for J & J Snack Foods Corp. is 116650 which is 23.85% above its average volume of 94181.
3. World Wrestling Entertainment (WWE)
11.2% sales growth and 55.51% return on equity
World Wrestling Entertainment, Inc., an integrated media and entertainment company, engages in the sports entertainment business in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It operates through three segments: Media, Live Events, and Consumer Products. The Media segment engages in the production and monetization of long-form and short-form video content across various platforms, including WWE Network, broadcast and pay television, and digital and social media, as well as filmed entertainment. The Live Events segment is involved in the sale of tickets; provision of event services; and sale of travel packages related to its live events. The Consumer Products segment engages in merchandising of WWE branded products, such as video games, toys, apparel, and books through licensing arrangements and direct-to-consumer sales, as well as through e-commerce platforms. World Wrestling Entertainment, Inc. was founded in 1980 and is headquartered in Stamford, Connecticut.
Earnings Per Share
As for profitability, World Wrestling Entertainment has a trailing twelve months EPS of $1.76.
PE Ratio
World Wrestling Entertainment has a trailing twelve months price to earnings ratio of 50.89. Meaning, the purchaser of the share is investing $50.89 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 55.51%.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Sep 13, 2022, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 0.61%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 3.8% and positive 2.9% for the next.
Sales Growth
World Wrestling Entertainment’s sales growth for the next quarter is 11.2%.
4. Vertex Pharmaceuticals (VRTX)
9.1% sales growth and 27.67% return on equity
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with CF 6 years of age or older who have at least one F508del mutation. Its pipeline includes VX-864 for the treatment of AAT deficiency, which is in Phase 2 clinical trial; VX-147 for the treatment of APOL1-mediated focal segmental glomerulosclerosis, or FSGS, and other serious kidney diseases which is in Phase 2 clinical trial; VX- 880, treatment for Type 1 Diabetes which is in Phase 1/2 clinical trial; VX-548, a NaV1.8 inhibitor for treatments of acute, neuropathic, musculoskeletal pain which is in Phase 2 clinical trial; and CTX001 for the treatment severe SCD and TDT which is in Phase 3 clinical trial. The company sells its products primarily to specialty pharmacy and specialty distributors in the United States, as well as specialty distributors and retail chains, and hospitals and clinics internationally. It has collaborations with Affinia Therapeutics, Inc.; Arbor Biotechnologies, Inc.; CRISPR Therapeutics AG.; Kymera Therapeutics, Inc.; Mammoth Biosciences, Inc.; Moderna, Inc.; Obsidian Therapeutics, Inc.; and Skyhawk Therapeutics, Inc.; as well as Ribometrix, Inc.; Genomics plc; Merck KGaA; Darmstadt, Germany, and X-Chem, Inc. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.
Earnings Per Share
As for profitability, Vertex Pharmaceuticals has a trailing twelve months EPS of $10.49.
PE Ratio
Vertex Pharmaceuticals has a trailing twelve months price to earnings ratio of 28.09. Meaning, the purchaser of the share is investing $28.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 27.67%.
Sales Growth
Vertex Pharmaceuticals’s sales growth is 10.8% for the present quarter and 9.1% for the next.
Volume
Today’s last reported volume for Vertex Pharmaceuticals is 129140 which is 90.94% below its average volume of 1426790.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 11.6% and positive 2.2% for the next.
5. Fiserv (FISV)
6.8% sales growth and 6.46% return on equity
Fiserv, Inc., together with its subsidiaries, provides payment and financial services technology worldwide. The company operates through Acceptance, Fintech, and Payments segments. The Acceptance segment provides point-of-sale merchant acquiring and digital commerce services; mobile payment services; security and fraud protection products; Carat, an omnichannel commerce solution; Clover, a cloud-based point-of-sale and business management platform; and Clover Connect, an independent software vendors platform. This segment distributes through various channels, including direct sales teams, strategic partnerships with agent sales forces, independent software vendors, financial institutions, and other strategic partners. The Fintech segment offers customer deposit and loan accounts, as well as manages an institution's general ledger and central information files. This segment also provides digital banking, financial and risk management, professional services and consulting, item processing and source capture, and other products and services. The Payments segment offers card transactions, such as debit, credit, and prepaid card processing and services; security and fraud protection products; card production; print services; and various network services, as well as non-card digital payment software and services, including bill payment, account-to-account transfers, person-to-person payments, electronic billing, and security and fraud protection products. It serves business, banks, credit unions, other financial institutions, merchants, and corporate clients. The company was incorporated in 1984 and is headquartered in Brookfield, Wisconsin.
Earnings Per Share
As for profitability, Fiserv has a trailing twelve months EPS of $1.28.
PE Ratio
Fiserv has a trailing twelve months price to earnings ratio of 90.78. Meaning, the purchaser of the share is investing $90.78 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.46%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 9.8%, now sitting on 17.01B for the twelve trailing months.
Yearly Top and Bottom Value
Fiserv’s stock is valued at $115.84 at 10:22 EST, below its 52-week high of $117.49 and way above its 52-week low of $87.03.
Moving Average
Fiserv’s value is way above its 50-day moving average of $103.69 and way higher than its 200-day moving average of $100.30.
Previous days news about Fiserv(FISV)
- : fiserv stock hits new 52-week high. According to MarketWatch on Wednesday, 15 February, "Fiserv, Global Payments Inc. , and Fidelity National Information Services Inc. all made mega-deals in the early part of 2019, but Fiserv has dramatically outperformed. "
